Detalhe da pesquisa
1.
Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion.
Blood
; 125(10): 1566-77, 2015 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25564401
2.
Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients.
Biol Blood Marrow Transplant
; 22(4): 690-697, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26740373
3.
Gene-expression signatures differ between different clinical forms of familial hemophagocytic lymphohistiocytosis.
Blood
; 121(7): e14-24, 2013 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23264592
4.
Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis.
Blood
; 117(15): e151-60, 2011 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21325597
5.
Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH.
Blood
; 118(22): 5794-8, 2011 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21881043
6.
Accuracy of flow cytometric perforin screening for detecting patients with FHL due to PRF1 mutations.
Blood
; 126(15): 1858-60, 2015 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26450956
7.
MicroRNA activation signature in patients with hemophagocytic lymphohistiocytosis and reversibility with disease-specific therapy.
J Allergy Clin Immunol
; 137(1): 309-312, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26194545
8.
Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations.
Clin Immunol
; 132(1): 116-23, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19398375
9.
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.
J Allergy Clin Immunol
; 121(6): 1473-83, 1483.e1-4, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18410960
10.
Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.
J Pediatr Gastroenterol Nutr
; 45(1): 22-31, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17592361
11.
Clinical flow cytometric screening of SAP and XIAP expression accurately identifies patients with SH2D1A and XIAP/BIRC4 mutations.
Cytometry B Clin Cytom
; 86(4): 263-71, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24616127
12.
Clinical Flow Cytometric Screening of SAP and XIAP Expression Accurately Identifies Patients with SH2D1A and XIAP/BIRC4 Mutations.
Cytometry B Clin Cytom
; 2014 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26305518
13.
Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis.
Front Immunol
; 4: 72, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23524976
14.
Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders.
J Immunol Methods
; 364(1-2): 1-13, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21110979
15.
A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.
Cytometry B Clin Cytom
; 76(5): 334-44, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19288545
16.
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Arthritis Rheum
; 56(3): 965-71, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17328073
17.
Patients of African ancestry with hemophagocytic lymphohistiocytosis share a common haplotype of PRF1 with a 50delT mutation.
J Pediatr
; 149(1): 134-7, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16860143
18.
Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
J Allergy Clin Immunol
; 118(6): 1312-9, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17157662
19.
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome.
Arthritis Res Ther
; 7(1): R30-7, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15642140
20.
Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
Blood
; 105(8): 3066-71, 2005 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15632210